Tejal Parekh
8Patents
7h-index
39Co-inventors
59Inventor score
Filing activity: Apr 3, 2001 → Apr 22, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7012066B2 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | Human Necessities | 83 | Expired |
| US6846802B2 | Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moieties | Human Necessities | 65 | Expired |
| US7244721B2 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | Human Necessities | 50 | Expired |
| US6800434B2 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | Human Necessities | 47 | Expired |
| US6838475B2 | Imidazolidinones as NS3-serine protease inhibitors of hepatitis C virus | Human Necessities | 42 | Expired |
| US7169760B2 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | Chemistry; Metallurgy | 24 | Expired |
| USRE43298E1 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | General | 15 | Active |
| US7595299B2 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.